GASTRITIS
Complete Nursing Notes | Clinical Concepts | Pathophysiology | Nursing Management | 25 Case-Based MCQs
NORCET 12 • Nursing Officer • RRB • ESIC • PGIMER • KGMU
Gastritis is an important gastrointestinal disorder frequently encountered in medical-surgical nursing examinations. Understanding its causes, clinical manifestations, diagnostic investigations, treatment and nursing priorities is essential for both clinical practice and competitive examinations.
- Define and classify gastritis.
- Understand the pathophysiology of acute and chronic gastritis.
- Identify clinical manifestations and complications.
- Understand diagnostic investigations and treatment.
- Apply nursing interventions in clinical scenarios.
- Solve difficult case-based and priority-based MCQs.
TABLE OF CONTENTS
- Definition
- Normal Anatomy and Physiology
- Classification of Gastritis
- Causes and Risk Factors
- Pathophysiology
- Clinical Manifestations
- Types of Gastritis in Detail
- Diagnostic Investigations
- Medical Management
- Nursing Management
- Complications
- Important Differences
- Mnemonics and Exam Tricks
- Quick Revision
- 25 Clinical and Case-Based MCQs
- References
1. DEFINITION OF GASTRITIS
Gastritis is inflammation of the gastric mucosa (inner lining of the stomach), which may develop suddenly or gradually depending on the underlying cause.
It can affect the entire stomach or specific regions such as the antrum or body of the stomach.
Basic Characteristics
- May be acute or chronic.
- May be erosive or non-erosive.
- Helicobacter pylori is an important cause of chronic gastritis.
- Long-term NSAID use can damage the gastric mucosal barrier.
- Some patients remain asymptomatic.
2. NORMAL ANATOMY AND PHYSIOLOGY OF STOMACH
Functions of the Stomach
- Temporary storage of food.
- Mechanical mixing and churning of food.
- Secretion of hydrochloric acid (HCl).
- Secretion of pepsinogen for protein digestion.
- Secretion of intrinsic factor for vitamin B12 absorption.
- Regulation of gastric emptying into the duodenum.
Important Gastric Cells
| Cell | Secretion | Function |
|---|---|---|
| Parietal cells | HCl and intrinsic factor | Acid production and vitamin B12 absorption |
| Chief cells | Pepsinogen | Protein digestion after conversion to pepsin |
| G cells | Gastrin | Stimulates gastric acid secretion |
| Mucous cells | Mucus and bicarbonate | Protect gastric mucosa |
| D cells | Somatostatin | Inhibits gastrin secretion |
| ECL cells | Histamine | Stimulates acid secretion through H2 receptors |
Normal Gastric Mucosal Protection
The stomach protects itself from acid through:- Mucus-bicarbonate barrier.
- Intact epithelial cell lining.
- Good mucosal blood circulation.
- Prostaglandin-mediated mucosal protection.
- Rapid epithelial cell repair.
3. CLASSIFICATION OF GASTRITIS
| Classification | Description |
|---|---|
| Acute gastritis | Sudden onset of gastric mucosal inflammation. |
| Chronic gastritis | Long-standing inflammation with possible glandular atrophy. |
| Erosive gastritis | Mucosal injury with erosions and possible bleeding. |
| Non-erosive gastritis | Inflammation without visible erosions. |
| Autoimmune gastritis | Immune-mediated destruction of parietal cells. |
| H. pylori gastritis | Chronic inflammation associated with H. pylori infection. |
| Reactive gastropathy | Chemical mucosal injury, commonly due to NSAIDs or bile reflux. |
Clinical Classification: Type A and Type B
| Feature | Type A | Type B |
|---|---|---|
| Cause | Autoimmune | Usually H. pylori |
| Common location | Body and fundus | Often antrum initially; may become widespread |
| Parietal cells | Destruction | Usually initially preserved |
| Intrinsic factor | Reduced | Usually preserved initially |
| Vitamin B12 | Deficiency risk | May be affected in advanced disease |
| Complications | Pernicious anemia, gastric neoplasia | Peptic ulcer, gastric cancer, MALT lymphoma |
Type A = Autoimmune
Type B = Bacterial (H. pylori)
4. CAUSES AND RISK FACTORS
A. Infectious Causes
- Helicobacter pylori: A spiral-shaped, gram-negative, urease-producing bacterium.
- Other infections are uncommon and more likely in immunocompromised individuals.
B. Drug-Induced Causes
- NSAIDs such as aspirin, ibuprofen and naproxen.
- Some chemotherapy medications.
- Other medications depending on the clinical context.
C. Chemical Causes
- Excessive alcohol exposure.
- Bile reflux.
- Caustic or irritating substances.
D. Autoimmune Causes
- Autoantibodies against gastric parietal cells.
- Antibodies against intrinsic factor.
E. Stress-Related Causes
- Severe burns.
- Major trauma.
- Sepsis.
- Shock.
- Critical illness and prolonged intensive care.
5. PATHOPHYSIOLOGY OF GASTRITIS
Basic Pathophysiology
Pathophysiology of H. pylori Gastritis
Pathophysiology of Autoimmune Gastritis
Parietal cell destruction → Intrinsic factor deficiency → Vitamin B12 malabsorption → Pernicious anemia.
6. CLINICAL MANIFESTATIONS
Common Signs and Symptoms
- Epigastric pain or discomfort.
- Nausea and vomiting.
- Loss of appetite.
- Abdominal bloating.
- Early satiety.
- Postprandial fullness.
- Belching and indigestion.
- Occasionally, hematemesis or melena.
Clinical Manifestations in Severe Cases
- Hematemesis (vomiting blood).
- Melena (black, tarry stool).
- Weakness and fatigue.
- Tachycardia.
- Hypotension.
- Signs of hypovolemic shock in severe bleeding.
- Vomiting blood or coffee-ground material.
- Black, tarry stools.
- Syncope or severe dizziness.
- Unexplained weight loss.
- Persistent vomiting.
- Progressive difficulty swallowing or severe anemia.
7. TYPES OF GASTRITIS IN DETAIL
1. Acute Gastritis
Acute gastritis develops suddenly and may be associated with medications, alcohol, infection or severe physiological stress.
Clinical Features:- Sudden epigastric discomfort.
- Nausea and vomiting.
- Loss of appetite.
- Possible gastric bleeding.
- Identify and remove the causative factor.
- Review NSAID exposure and other medications.
- Acid suppression when indicated.
- Fluid replacement if dehydration is present.
- Endoscopic assessment if significant bleeding occurs.
2. Chronic Gastritis
Chronic gastritis is prolonged gastric mucosal inflammation that may lead to atrophy, intestinal metaplasia and other complications.
Common Causes:- H. pylori infection.
- Autoimmune gastritis.
- Long-standing chemical irritation.
3. H. pylori Gastritis
Helicobacter pylori is a gram-negative, curved or spiral-shaped bacterium that colonizes the gastric mucosa.
Important Characteristics:- Urease positive.
- Gram-negative.
- Associated with chronic gastritis.
- Associated with peptic ulcer disease.
- Associated with gastric adenocarcinoma and gastric MALT lymphoma.
4. Autoimmune Gastritis
Autoimmune gastritis occurs when the immune system attacks gastric parietal cells and may produce antibodies against intrinsic factor.
Important Findings:- Reduced intrinsic factor.
- Reduced vitamin B12 absorption.
- Vitamin B12 deficiency.
- Pernicious anemia.
- Possible iron deficiency, sometimes preceding B12 deficiency.
- Increased risk of certain gastric neoplasms.
5. Erosive Gastritis
Erosive gastritis involves damage to the gastric mucosal surface, producing superficial erosions and potentially significant bleeding.
Causes:- NSAIDs.
- Alcohol.
- Severe physiological stress.
- Chemical injury.
6. Stress-Related Gastritis
Stress-related mucosal disease occurs in critically ill patients due to impaired mucosal defense and reduced gastric perfusion.
High-Risk Patients:- Patients with coagulopathy.
- Patients with prolonged mechanical ventilation, particularly when additional risk factors exist.
- Patients with shock or severe sepsis.
- Patients with major burns or severe trauma.
8. DIAGNOSTIC INVESTIGATIONS
| Investigation | Purpose | Important Finding |
|---|---|---|
| Upper GI endoscopy | Visualizes gastric mucosa | Erythema, erosions, ulcers or other abnormalities |
| Gastric biopsy | Histopathological diagnosis | Inflammation, atrophy, H. pylori or metaplasia |
| Urea breath test | Detects active H. pylori infection | Increased labelled CO2 in exhaled breath |
| Stool antigen test | Detects active H. pylori infection | H. pylori antigen present |
| CBC | Detects anemia and blood loss | Low hemoglobin may occur |
| Vitamin B12 level | Evaluates deficiency | Low B12 in autoimmune gastritis |
| Iron studies | Evaluates iron deficiency | Low ferritin may occur |
| Intrinsic factor antibody | Supports autoimmune gastritis | Positive result supports diagnosis |
| Parietal cell antibody | Supports autoimmune gastritis | May be positive |
| Fecal occult blood test | Detects hidden GI bleeding | Positive result may indicate bleeding |
Important Diagnostic Test: H. pylori
1. Urea Breath Test- Non-invasive test.
- Detects active H. pylori infection.
- Useful for confirming eradication after treatment.
- Non-invasive.
- Detects active infection.
- Useful for diagnosis and test of cure.
- Useful when alarm features or other clinical indications are present.
- Allows direct visualization and tissue sampling.
- Can identify ulcers, atrophy, metaplasia and other pathology.
9. MEDICAL MANAGEMENT
Treatment depends on the underlying cause, severity, endoscopic findings and associated complications.
A. Proton Pump Inhibitors (PPIs)
| Drug | Action |
|---|---|
| Omeprazole | Reduces gastric acid secretion. |
| Pantoprazole | Inhibits gastric H+/K+ ATPase. |
| Esomeprazole | Suppresses gastric acid secretion. |
| Lansoprazole | Reduces gastric acid secretion. |
B. H2 Receptor Blockers
- Famotidine.
- Reduces acid secretion by blocking histamine H2 receptors.
C. Antacids
- Magnesium hydroxide.
- Aluminium hydroxide.
- Calcium carbonate.
Antacids neutralize existing gastric acid and provide symptomatic relief.
D. Mucosal Protective Agents
- Sucralfate.
- Bismuth compounds in appropriate regimens.
E. H. pylori Eradication Therapy
Confirmed H. pylori infection requires an appropriate combination of antibiotics and acid suppression. Regimen selection depends on local resistance patterns, previous antibiotic exposure, allergies and current clinical guidelines.
- Optimized bismuth quadruple therapy for 14 days is a preferred empiric first-line option when antibiotic susceptibility is unknown in the guideline population.
- It includes a PPI, bismuth, tetracycline and metronidazole.
- Do not routinely use clarithromycin- or levofloxacin-containing regimens empirically without demonstrated susceptibility.
- Alternative regimens may be appropriate depending on susceptibility, allergy and clinical circumstances.
The exact treatment regimen should follow current local specialist guidance and prescribing protocols.
Test of Cure – Very Important
| Parameter | Recommendation |
|---|---|
| When to test? | At least 4 weeks after completing antibiotics. |
| PPIs / PCABs | Withhold for approximately 2 weeks before testing, under medical guidance. |
| Bismuth and antibiotics | Withhold for at least 4 weeks before testing. |
| Preferred tests | Urea breath test or stool antigen test. |
F. Autoimmune Gastritis Management
- Vitamin B12 replacement when deficient.
- Iron replacement if iron deficiency is present.
- Evaluation for associated autoimmune disorders when indicated.
- Appropriate endoscopic surveillance based on individual risk.
G. Management of Acute GI Bleeding
- Assess airway, breathing and circulation.
- Check vital signs and level of consciousness.
- Establish IV access.
- Collect CBC, coagulation profile and blood grouping/crossmatch as indicated.
- Administer IV fluids and blood products according to clinical need.
- Urgent endoscopic assessment and hemostasis when indicated.
10. NURSING MANAGEMENT
A. Nursing Assessment
- Assess location, severity and duration of abdominal pain.
- Ask about nausea, vomiting and appetite.
- Assess stool colour and consistency.
- Check for hematemesis and melena.
- Review NSAID, aspirin and alcohol exposure.
- Monitor vital signs.
- Assess hydration and nutritional status.
- Review laboratory reports.
B. Nursing Diagnoses
| Nursing Diagnosis | Related Factors |
|---|---|
| Acute Pain | Gastric mucosal inflammation or injury |
| Nausea | Gastric irritation |
| Imbalanced Nutrition: Less Than Body Requirements | Reduced appetite and poor oral intake |
| Deficient Fluid Volume | Repeated vomiting or bleeding |
| Risk for Bleeding | Erosive mucosal injury |
| Deficient Knowledge | Lack of information about disease and treatment |
C. Nursing Interventions
1. Pain Management- Assess pain using an appropriate pain scale.
- Monitor abdominal symptoms.
- Administer prescribed medication.
- Observe response to treatment.
- Encourage small, frequent meals if tolerated.
- Provide a balanced diet.
- Avoid individually identified trigger foods.
- Monitor oral intake and body weight.
- Encourage adequate fluid intake when not contraindicated.
- Monitor vomitus and stool for blood.
- Observe for tachycardia and hypotension.
- Monitor hemoglobin and hematocrit.
- Report signs of gastrointestinal bleeding immediately.
- Administer PPIs as prescribed, commonly before meals.
- Educate the patient about completing the entire H. pylori antibiotic course.
- Monitor adverse drug reactions.
- Explain that bismuth may darken the tongue and stool.
- Discourage unsupervised NSAID use.
- Avoid smoking.
- Limit or avoid alcohol.
- Avoid unnecessary NSAIDs.
- Maintain proper hand hygiene and safe food and water practices.
- Follow the prescribed treatment plan.
- Attend follow-up appointments and H. pylori test of cure.
D. Priority Nursing Action
11. COMPLICATIONS OF GASTRITIS
- Gastrointestinal bleeding: Due to erosions or ulceration.
- Peptic ulcer disease: Especially associated with H. pylori infection.
- Iron deficiency anemia: May occur due to chronic blood loss or impaired iron absorption.
- Pernicious anemia: Associated with autoimmune destruction of parietal cells and intrinsic factor deficiency.
- Gastric atrophy: Loss of normal gastric glands.
- Intestinal metaplasia: Replacement of gastric epithelium with intestinal-type epithelium.
- Gastric adenocarcinoma: Risk increases with certain chronic gastritis patterns, particularly H. pylori-associated atrophic gastritis.
- MALT lymphoma: Associated with chronic H. pylori infection.
Complication Flowchart
12. IMPORTANT DIFFERENCES FOR EXAMINATIONS
Gastritis vs Peptic Ulcer Disease
| Feature | Gastritis | Peptic Ulcer |
|---|---|---|
| Definition | Inflammation of gastric mucosa | Deeper mucosal defect extending through muscularis mucosae |
| Site | Stomach | Stomach or duodenum |
| Symptoms | Dyspepsia, nausea, discomfort | Epigastric pain, possible bleeding |
| Complication | Erosion and bleeding | Bleeding, perforation, obstruction |
Acute vs Chronic Gastritis
| Feature | Acute | Chronic |
|---|---|---|
| Onset | Sudden | Gradual or persistent |
| Duration | Short-term | Long-term |
| Common cause | NSAIDs, alcohol, severe illness | H. pylori, autoimmunity |
| Complication | Acute bleeding | Atrophy, metaplasia, anemia |
Gastritis vs Gastroenteritis
| Feature | Gastritis | Gastroenteritis |
|---|---|---|
| Main organ | Stomach | Stomach and intestines |
| Common symptoms | Epigastric pain, nausea | Diarrhea, vomiting, abdominal cramps |
| Common cause | H. pylori, NSAIDs | Viral, bacterial or parasitic infection |
13. HIGH-YIELD MNEMONICS AND EXAM TRICKS
- H – H. pylori
- A – Alcohol / Autoimmune
- N – NSAIDs
- S – Severe physiological stress
- U – Urease positive
- G – Gram negative
- R – Resides in gastric mucus
- A – Associated with ulcers
- M – MALT lymphoma association
Parietal cell ↓ → Intrinsic factor ↓ → Vitamin B12 ↓ → Pernicious anemia.
- A – Airway
- B – Breathing
- C – Circulation
14. QUICK REVISION – NORCET HIGH-YIELD POINTS
| Question | Correct Concept |
|---|---|
| Most important infectious cause of chronic gastritis? | H. pylori |
| H. pylori is what type of organism? | Gram-negative, urease-positive bacterium |
| Which cell secretes HCl? | Parietal cell |
| Which cell secretes pepsinogen? | Chief cell |
| Intrinsic factor is secreted by? | Parietal cell |
| Intrinsic factor deficiency causes? | Vitamin B12 deficiency |
| Autoimmune gastritis commonly affects? | Body and fundus |
| Best non-invasive active H. pylori tests? | Urea breath test and stool antigen |
| Important drug causing reactive gastropathy? | NSAIDs |
| Drug class inhibiting proton pump? | PPIs |
| H. pylori test of cure? | At least 4 weeks after antibiotics |
| PPIs before test of cure? | Withhold for about 2 weeks |
| Black tarry stool is called? | Melena |
| Vomiting blood is called? | Hematemesis |
| H. pylori is associated with which lymphoma? | MALT lymphoma |
15. MCQs PRACTICE TEST – 25 CLINICAL & CASE-BASED QUESTIONS
- Total Questions: 25
- Suggested Time: 25 Minutes
- Difficulty: Moderate to Difficult
- Question Type: Clinical, Case-Based, Priority-Based and Conceptual
- Each question has an answer and explanation.
- Escherichia coli
- Helicobacter pylori
- Salmonella typhi
- Clostridium difficile
Show Answer & Explanation
Correct Answer: B. Helicobacter pyloriH. pylori is a spiral-shaped, gram-negative, urease-positive bacterium and an important cause of chronic active gastritis and peptic ulcer disease.
- Increased intrinsic factor secretion
- Inhibition of prostaglandin synthesis
- Increased mucus secretion
- Increased gastric bicarbonate secretion
Show Answer & Explanation
Correct Answer: B. Inhibition of prostaglandin synthesisNSAIDs inhibit cyclooxygenase enzymes, reducing prostaglandin synthesis. This decreases mucus and bicarbonate protection and can impair mucosal blood flow.
- Pepsinogen
- Gastrin
- Intrinsic factor
- Secretin
Show Answer & Explanation
Correct Answer: C. Intrinsic factorAutoimmune destruction of parietal cells reduces intrinsic factor secretion, causing impaired vitamin B12 absorption and potentially pernicious anemia.
- Stress-related mucosal disease
- Achalasia cardia
- Cholelithiasis
- Ulcerative colitis
Show Answer & Explanation
Correct Answer: A. Stress-related mucosal diseaseSevere burns and critical illness can impair gastric mucosal perfusion and protective mechanisms, resulting in acute erosions and gastrointestinal bleeding.
- Paracetamol
- Proton pump inhibitor
- Vitamin C
- Oral iron
Show Answer & Explanation
Correct Answer: B. Proton pump inhibitorPPIs suppress H. pylori activity and can cause false-negative urea breath and stool antigen tests. They are generally withheld for 2 weeks before testing under medical supervision.
- Provide oral fluids
- Administer antacid orally
- Assess ABCs and initiate emergency resuscitation
- Provide a high-protein diet
Show Answer & Explanation
Correct Answer: C. Assess ABCs and initiate emergency resuscitationThe patient has signs of hemodynamic instability due to possible major GI hemorrhage. Airway, breathing and circulation take priority, followed by IV access and resuscitation.
- Immediately after the last antibiotic dose
- After 24 hours
- At least 4 weeks after completion of antibiotics
- After 48 hours
Show Answer & Explanation
Correct Answer: C. At least 4 weeks after completion of antibioticsTesting should occur at least 4 weeks after antibiotics, with PPIs or PCABs withheld for approximately 2 weeks before testing to reduce false-negative results.
- Chief cell
- Parietal cell
- G cell
- D cell
Show Answer & Explanation
Correct Answer: B. Parietal cellParietal cells secrete hydrochloric acid and intrinsic factor.
- Vitamin B12 deficiency
- Vitamin K excess
- Hypercalcemia
- Elevated platelet count as the defining feature
Show Answer & Explanation
Correct Answer: A. Vitamin B12 deficiencyVitamin B12 deficiency causes megaloblastic anemia with macrocytosis. Neurological manifestations may also occur.
- Serum sodium
- Urea breath test
- ECG
- Serum amylase
Show Answer & Explanation
Correct Answer: B. Urea breath testThe urea breath test detects active H. pylori infection and is also useful for confirming eradication.
- H. pylori has no association with lymphoma
- H. pylori is associated with gastric MALT lymphoma
- MALT lymphoma is caused by vitamin C deficiency
- It is exclusively associated with NSAIDs
Show Answer & Explanation
Correct Answer: B. H. pylori is associated with gastric MALT lymphomaChronic H. pylori stimulation of gastric lymphoid tissue can contribute to MALT lymphoma development.
- Hematochezia
- Melena
- Steatorrhea
- Acholic stool
Show Answer & Explanation
Correct Answer: B. MelenaMelena refers to black, tarry stools, generally resulting from digested blood in the gastrointestinal tract.
- Antacids
- H2 blockers
- Proton pump inhibitors
- Antiemetics
Show Answer & Explanation
Correct Answer: C. Proton pump inhibitorsPPIs inhibit the final step of gastric acid secretion by blocking the H+/K+ ATPase pump in parietal cells.
- Pernicious anemia
- Diabetes insipidus
- Nephrotic syndrome
- Acute pancreatitis
Show Answer & Explanation
Correct Answer: A. Pernicious anemiaIntrinsic factor antibodies interfere with vitamin B12 absorption and are strongly associated with pernicious anemia.
- Triple therapy
- Optimized bismuth quadruple therapy
- Antacid therapy
- Monotherapy
Show Answer & Explanation
Correct Answer: B. Optimized bismuth quadruple therapyThis four-component regimen is an important empiric treatment option in the 2024 ACG H. pylori guideline when susceptibility is unknown.
- Stop every medication immediately
- Explain that bismuth can darken stools, but assess for bleeding symptoms
- Ignore all black stools
- Recommend additional NSAIDs
Show Answer & Explanation
Correct Answer: B. Explain that bismuth can darken stools, but assess for bleeding symptomsBismuth can cause harmless darkening of the tongue and stool. However, true melena must not be dismissed, particularly when accompanied by dizziness, weakness or hemodynamic changes.
- Routine high-dose NSAIDs
- Stress ulcer prophylaxis with a PPI or H2 blocker
- Unrestricted alcohol intake
- Routine laxatives for all patients
Show Answer & Explanation
Correct Answer: B. Stress ulcer prophylaxis with a PPI or H2 blockerPatients with significant risk factors for stress-related upper GI bleeding may require pharmacological prophylaxis. It is not indicated routinely for every hospitalized patient.
- Serum ferritin
- Serum sodium
- Serum potassium
- Serum bilirubin only
Show Answer & Explanation
Correct Answer: A. Serum ferritinFerritin reflects iron stores. Low ferritin strongly supports iron deficiency in the appropriate clinical context.
- Reassure that these are normal findings
- Recommend only dietary modification
- Report alarm features and facilitate prompt medical evaluation
- Advise the patient to stop all food intake permanently
Show Answer & Explanation
Correct Answer: C. Report alarm features and facilitate prompt medical evaluationUnexplained weight loss, persistent vomiting and anemia require evaluation for significant underlying pathology, including malignancy or bleeding.
- It increases stomach acid
- It suppresses gastric acid secretion and is generally taken before meals for optimal effect
- It directly kills H. pylori alone
- It increases intrinsic factor secretion
Show Answer & Explanation
Correct Answer: B. It suppresses gastric acid secretion and is generally taken before meals for optimal effectPPIs are commonly administered before meals to maximize inhibition of activated proton pumps. They do not independently eradicate H. pylori.
- Hypovolemic shock
- Hyperthyroidism
- Hypocalcemia
- Respiratory alkalosis alone
Show Answer & Explanation
Correct Answer: A. Hypovolemic shockBlood loss reduces circulating volume and tissue perfusion. Tachycardia, hypotension, pallor and restlessness are important warning signs.
- Gastric adenocarcinoma
- Acute appendicitis
- Renal calculi
- Glaucoma
Show Answer & Explanation
Correct Answer: A. Gastric adenocarcinomaAtrophic gastritis and intestinal metaplasia are recognized premalignant gastric conditions requiring risk-based follow-up.
- Hair texture
- Hydration status and fluid balance
- Visual acuity
- Hearing ability
Show Answer & Explanation
Correct Answer: B. Hydration status and fluid balanceRepeated vomiting may cause dehydration and electrolyte abnormalities. Monitor intake/output, vital signs and relevant laboratory values.
- Yes, symptom relief means the infection is cured
- Stop the PPI but continue random antibiotics
- Complete the full prescribed eradication regimen
- Take antibiotics only when pain returns
Show Answer & Explanation
Correct Answer: C. Complete the full prescribed eradication regimenSymptom improvement does not prove eradication. Incomplete therapy can result in treatment failure and antimicrobial resistance.
- Assess airway and breathing
- Monitor blood pressure and pulse
- Establish IV access as prescribed
- Encourage immediate oral food and fluids
Show Answer & Explanation
Correct Answer: D. Encourage immediate oral food and fluidsDuring significant acute GI bleeding, oral intake should not be encouraged. The patient may require urgent endoscopy and anesthesia; follow emergency protocols and keep the patient NPO as directed.
ANSWER KEY – QUICK CHECK
| Q.No. | Answer | Q.No. | Answer | Q.No. | Answer |
|---|---|---|---|---|---|
| 1 | B | 10 | B | 19 | C |
| 2 | B | 11 | B | 20 | B |
| 3 | C | 12 | B | 21 | A |
| 4 | A | 13 | C | 22 | A |
| 5 | B | 14 | A | 23 | B |
| 6 | C | 15 | B | 24 | C |
| 7 | C | 16 | B | 25 | D |
| 8 | B | 17 | B | ||
| 9 | A | 18 | A |
SELF-EVALUATION
| Score | Performance |
|---|---|
| 22–25 | Excellent – Strong clinical understanding |
| 18–21 | Very Good – Revise a few concepts |
| 14–17 | Good – Review pathophysiology and management |
| 10–13 | Needs Improvement – Revise complete notes |
| Below 10 | Re-study the topic and attempt again |
16. REFERENCES AND FURTHER READING
- NIDDK – Gastritis and Gastropathy: Definition, Causes, Diagnosis and Treatment.
- ACG Clinical Guideline: Treatment of Helicobacter pylori Infection, 2024.
- Brunner & Suddarth's Textbook of Medical-Surgical Nursing.
- Lewis's Medical-Surgical Nursing.
Recommended Online References:
- NIDDK – Gastritis & Gastropathy
- ACG – H. pylori Treatment Guideline
- 2024 ACG Clinical Guideline – PubMed